This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

NovaBay Pharmaceuticals Inc (NBY)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 10.50M 12.74M 8.43M 11.53M
Receivables 784.00K 943.00K 3.00K 500.00K
Inventories 231.00K 23.00K 0.00 0.00
Other Current Assets 0.00 445.00K 0.00 0.00
Total Current Assets 14.79M 18.28M 14.56M 13.75M
Property, Plant & Equipment, Gross 2.37M 2.23M 3.08M 3.03M
Accumulated Depreciation & Depletion 1.65M 1.34M 1.82M 1.44M
Property, Plant & Equipment, Net 718.00K 891.00K 1.27M 1.59M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 141.00K 63.00K 135.00K 174.00K
Total Non-Current Assets 859.00K 954.00K 1.40M 1.76M
Liabilities & Shareholder Equity
Total Assets 15.65M 19.24M 15.96M 15.52M
Accounts Payable 1.67M 455.00K 472.00K 406.00K
Short Term Debt 0.00 0.00 0.00 106.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 3.63M 3.17M 2.84M 2.72M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 136.00K 60.00K 0.00 0.00
Other Non-Current Liabilities 3.37M 1.95M 3.78M 2.30M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.51M 2.01M 3.78M 2.30M
Total Liabilities 7.13M 5.19M 6.62M 5.03M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 8.52M 14.05M 9.34M 10.49M
Common Par 446.00K 369.00K 286.00K 234.00K
Additional Paid In Capital 64.44M 54.00M 42.39M 38.47M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -56.35M -40.31M -33.28M -28.20M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -15.00K -13.00K -44.00K -14.00K
Total Capitalization 8.52M 14.05M 9.34M 10.49M
Total Equity 8.52M 14.05M 9.34M 10.49M
Total Liabilities & Stock Equity 15.65M 19.24M 15.96M 15.52M
Total Common Shares Outstanding 44.62M 36.92M 28.59M 23.39M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 38.18M 29.45M 25.77M 23.33M
Diluted Weighted Shares Outstanding 38.18M 29.45M 25.77M 23.33M
Number of Employees 29 26 27 43
Number of Part-Time Employees 5 4 0 0
NBY News

NBY NovaBay Pharmaceuticals Inc

Analysts Ratings for NBY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NBY ANALYST REPORT

Brokerage Partners

NBY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs